The transcatheter aortic valve implantation market can be divided globally. The market can be divided into transapical, transfemoral, and transaortic implantations depending on the surgery. The segment with the biggest Transcatheter Aortic Valve Implantation (TAVI) Market share in 2018 was transfemoral implantation, and it is anticipated that this pattern would hold throughout the forecast period. Also, increased investment for research & development activities, new product releases, and the presence of attractive reimbursement policies are some of the factors projected to provide a fillip to the market. The average length of hospital stay is expected to decrease as minimally invasive surgery (MIS) becomes more widely used and as transcatheter aortic valve replacement technology advances. This will likely result in lower healthcare costs.